Wuhan YZY Biopharma Co., Ltd. (HKG:2496)
Hong Kong · Delayed Price · Currency is HKD 5.70
0.00 (0.00%)
At close: Mar 6, 2026
Wuhan YZY Biopharma Market Cap
Wuhan YZY Biopharma has a market cap or net worth of 1.1 billion as of March 6, 2026. Its market cap has decreased by -18.57% in one year.
Market Cap
1.10B
Enterprise Value
1.09B
Revenue
163.65M
Ranking
n/a
PE Ratio
n/a
Stock Price
5.70
Market Cap Chart
Since September 25, 2023, Wuhan YZY Biopharma's market cap has decreased from 3.09B to 1.10B, a decrease of -64.22%. That is a compound annual growth rate of -34.30%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 6, 2026 | 1.10B | -28.93% |
| Dec 31, 2025 | 1.55B | -3.14% |
| Dec 31, 2024 | 1.61B | -6.97% |
| Dec 29, 2023 | 1.73B | -44.13% |
| Sep 25, 2023 | 3.09B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| ImmuneOnco Biopharmaceuticals (Shanghai) | 1.50B |
| Immunotech Biopharm | 1.45B |
| CANbridge Pharmaceuticals | 1.40B |
| Beijing Biostar Pharmaceuticals | 1.33B |
| Kintor Pharmaceutical | 1.26B |
| Shanghai Bio-heart Biological Technology | 1.13B |
| HighTide Therapeutics | 1.09B |
| Brii Biosciences | 995.72M |